FDA announcements or press releases from Nyxoah

Nyxoah Launches App-Controlled Genio Device in UK for Sleep Apnoea Relief, Fitting First Patients

Dec 13, 2024, 09:57 AM

Nyxoah has announced the commercial launch of its innovative therapy, Genio, in the United Kingdom. This new app-controlled nerve stimulator aims to provide relief for millions suffering from sleep apnoea. The device works by stimulating the nerves in the tongue, helping patients breathe more easily during the night. The first patients in the UK have already been fitted with this microchip, marking a significant advancement in the treatment options available for sleep apnoea. This development is expected to bring relief not only to patients but also to their partners, who often endure the effects of snoring associated with the condition.